Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease

Neurology

Volumn 64, Issue 3, 2005, Pages 545-547

  Zaja Milatovic, S ^a   Milatovic, D ^a   Schantz, A M ^a   Zhang, J ^a   Montine, K S ^a   Samii, A ^a   Deutch, A Y ^b   Montine, T J ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; MOUSE; NEOSTRIATUM; NERVE CELL DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN;

EID: 13244287684     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000150591.33787.A4     Document Type: Article

References (10)

1. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, et al. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 2000;23:S8-19.
2. Goto S, Hirano A, Matsumoto S. Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison to those in Parkinson's and Alzheimer's diseases. Ann Neurol 1990;27:520-527.
3. McNeill TH, Brown SA, Rafols JA, Shoulson I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res 1988;455:148-152.
4. Mirra SS, Hyman BT. Ageing and dementia. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology. London: Arnold, 2002:195-272.
5. Glaser EM, Van der Loos H. Analysis of thick brain sections by obverse-reverse computer microscopy: application of a new, high clarity Golgi-Nissl stain. J Neurosci Methods 1981;4:117-125.
6. Roitman MF, Na E, Anderson G, Jones TA, Bernstein IL. Induction of a salt appetite alters dendritic morphology in nucleus accumbens and sensitizes rats to amphetamine. J Neurosci 2002;22:RC225.
7. Koenderink MJ, Uylings HB. Morphometric dendritic field analysis of pyramidal neurons in the human prefrontal cortex: relation to section thickness. J Neurosci Methods 1996;64:115-122.
8. Arbuthnott GW, Ingham CA, Wickens JR. Dopamine and synaptic plasticity in the neostriatum. J Anat 2000;196:587-596.
9. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318:876-880.
10. Luo J, Kaplitt MG, Fitzsimmons HL, et al. Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science 2002;298:425-429.